 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
MiSeq Customers, WGS Service, and T21 Test Developers Drive Illumina's Clinical Business
October 24, 2012
MiSeq Customers, WGS Service, and T21 Test Developers Drive Illumina's Clinical Business
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News - Illumina Focuses on Reproductive Health; May Modify MiSeq/HiSeq for Different Clinical Needs
January 30, 2013 / Clinical Sequencing News - Illumina in Discussions with 100 Potential Clinical Customers for MiSeq, Plans Cancer Diagnostics
April 25, 2012 / Clinical Sequencing News - Illumina Sees Growing Commercial Customer Base; Doubled Clinical HiSeq Placements in 2011
February 8, 2012 / Clinical Sequencing News - Illumina and Siemens to Co-Develop MDx Tests on the MiSeq
November 2, 2011 / Clinical Sequencing News